Literature DB >> 12642355

Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.

Michel Marcil1, Rachel Bissonnette, Jérôme Vincent, Larbi Krimbou, Jacques Genest.   

Abstract

BACKGROUND: Prospective studies have examined the relationship between coronary artery disease and low plasma levels of high-density lipoprotein cholesterol (HDL-C). METHODS AND
RESULTS: We investigated the causes of hypoalphalipoproteinemia (HypoA; HDL-C <5th percentile) in 64 subjects (12 women and 52 men). Apolipoprotein AI-mediated cellular cholesterol and phospholipid efflux were measured in fibroblasts from HypoA subjects, 9 controls, 2 patients with Tangier disease, and 5 patients with hyperalphalipoproteinemia. A phospholipid efflux defect was defined as <70% of controls. Mean HDL-C was 0.49+/-0.21 mmol/L. Cholesterol and phospholipid efflux correlated strongly (r=0.72, P<0.001). Phospholipid efflux and HDL-C (r=0.64, P<0.001) correlated in HypoA subjects. However, phospholipid or cholesterol efflux was no longer a determinant of HDL-C levels at higher levels (> approximately 1.0 mmol/L) of HDL-C. In HypoA subjects, 4 cases of Tangier disease and 6 of familial HDL deficiency (heterozygous Tangier disease) were identified (10 of 64; 16%). In the remaining 54 subjects, mean lipid efflux was not significantly different from controls and subjects with hyperalphalipoproteinemia. A phospholipid efflux defect was identified in 7 additional HypoA subjects, and a cholesterol efflux defect was detected in 11 subjects. In 2 of these subjects, the ABCA1 gene was ruled out as the cause of the efflux defect, while in 3, the low HDL-C trait segregated with the ABCA1 gene locus.
CONCLUSIONS: Lipidation of lipid-poor apolipoprotein AI may not be a major determinant of cholesterol accumulation within more mature HDL particles and increasing cholesterol or phospholipid efflux beyond normal levels may not lead to increase in plasma HDL-C levels. ABCA1 is essential in the initial steps of HDL formation but other plasma events are major modulators of HDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642355     DOI: 10.1161/01.cir.0000056764.53152.f9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 2.  Cellular cholesterol homeostasis in vascular endothelial cells.

Authors:  Hajj Hassan Hassan; Maxime Denis; Larbi Krimbou; Michel Marcil; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

3.  Exome sequencing identifies 2 rare variants for low high-density lipoprotein cholesterol in an extended family.

Authors:  M V Prasad Linga Reddy; Iulia Iatan; Daphna Weissglas-Volkov; Elina Nikkola; Blake E Haas; Miina Juvonen; Isabelle Ruel; Miina Juvonen Isabelle Ruel; Janet S Sinsheimer; Jacques Genest; Päivi Pajukanta
Journal:  Circ Cardiovasc Genet       Date:  2012-08-25

4.  The WWOX gene modulates high-density lipoprotein and lipid metabolism.

Authors:  Iulia Iatan; Hong Y Choi; Isabelle Ruel; M V Prasad Linga Reddy; Hyunsuk Kil; Jaeho Lee; Mohammad Abu Odeh; Zaidoun Salah; Muhannad Abu-Remaileh; Daphna Weissglas-Volkov; Elina Nikkola; Mete Civelek; Zuhier Awan; Carlo M Croce; Rami I Aqeilan; Päivi Pajukanta; C Marcelo Aldaz; Jacques Genest
Journal:  Circ Cardiovasc Genet       Date:  2014-05-28

5.  IMB2026791, a xanthone, stimulates cholesterol efflux by increasing the binding of apolipoprotein A-I to ATP-binding cassette transporter A1.

Authors:  Jikai Liu; Zhongbing Zhang; Yanni Xu; Tingting Feng; Wei Jiang; Zhuorong Li; Bin Hong; Zijian Xie; Shuyi Si
Journal:  Molecules       Date:  2012-03-07       Impact factor: 4.411

6.  Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Patrick Linsel-Nitschke; Henning Jansen; Zouhair Aherrarhou; Stefanie Belz; Björn Mayer; Wolfgang Lieb; Fritz Huber; Werner Kremer; Hans-Robert Kalbitzer; Jeanette Erdmann; Heribert Schunkert
Journal:  Lipids Health Dis       Date:  2009-04-06       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.